<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="[!info]
🌱 來自: [[inflammatory bowel disease]]
 extraintestinal manifestations of inflammatory bowel disease CATEGORYCLINICAL COURSETREATMENTRheumatologic disorders (5–20%)Peripheral arthritisAsymmetric, migratory"><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-mlkgi530p-htlin222.vercel.app/api/blog?templateTitle=extraintestinal manifestations of inflammatory bowel disease"><title>extraintestinal manifestations of inflammatory bowel disease</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=alternate type=application/rss+xml href=https://www.physician.tw//feed.xml title><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.acd6336f837a791cf1889bb120dfb142.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.734684aaae31120fff8649b44853d05d.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.b90ca0497a29c18cafd913cdb863e820.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=搜尋 placeholder="請輸入像是：hypertension 之類的來看沒有沒什麼有趣的🎳"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>蜥蜴花園🦎🌱🪴🌲</a></h1><div class=spacer></div><div id=search-icon><p>搜尋</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">搜尋圖示</title><desc id="desc">打開搜尋圖標</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>明亮模式</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>黑暗模式</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>extraintestinal manifestations of inflammatory bowel disease</h1><p class=meta>最後更新於
Aug 10, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/extraintestinal%20manifestations%20of%20inflammatory%20bowel%20disease.md rel=noopener>🪚 編輯原始文件</a></p><ul class=tags><li><a href=https://www.physician.tw/tags/building/>building</a></li></ul><blockquote class=info-callout><p></p><p>🌱 來自: <a href=/inflammatory-bowel-disease rel=noopener class=internal-link data-src=/inflammatory-bowel-disease>inflammatory bowel disease</a></p></blockquote><a href=#extraintestinal-manifestations-of-inflammatory-bowel-disease><h1 id=extraintestinal-manifestations-of-inflammatory-bowel-disease><span class=hanchor arialabel=Anchor># </span>extraintestinal manifestations of inflammatory bowel disease</h1></a><table role=presentation><thead><tr><th align xt-marked=ok>CATEGORY</th><th align xt-marked=ok>CLINICAL COURSE</th><th align xt-marked=ok>TREATMENT</th></tr></thead><tbody><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink xt-marked=ok>Rheumatologic disorders (5–20%)</strong></td></tr><tr><td align xt-marked=ok>Peripheral arthritis</td><td align><p xt-marked=ok>Asymmetric, migratory</p><p xt-marked=ok>Parallels bowel activity</p></td><td align xt-marked=ok>Reduce bowel inflammation</td></tr><tr><td align xt-marked=ok>Sacroiliitis</td><td align><p xt-marked=ok>Symmetric: spine and hip joints</p><p xt-marked=ok>Independent of bowel activity</p></td><td align xt-marked=ok>Steroids, injections, methotrexate, anti-TNF</td></tr><tr><td align xt-marked=ok>Ankylosing spondylitis</td><td align><p xt-marked=ok>Gradual fusion of spine</p><p xt-marked=ok>Independent of bowel activity</p><p xt-marked=ok>Two-thirds have HLA-B27 antigen</p></td><td align xt-marked=ok>Physical therapy, steroids, injections, methotrexate, anti-TNF, IL-17 inhibitors, tofacitinib</td></tr><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink xt-marked=ok>Metabolic bone disorders (up to 40% of patients)</strong></td></tr><tr><td align xt-marked=ok>Osteoporosis</td><td align><p xt-marked=ok>Risk increased by glucocorticoids, cyclosporine, methotrexate, total parenteral nutrition, malabsorption, and inflammation</p><p xt-marked=ok>Fracture rates highest in the elderly (age >60)</p></td><td align xt-marked=ok>Screening with DEXA scan, check vitamin D levels, treat if osteoporosis or osteopenia on long-term corticosteroids</td></tr><tr><td align xt-marked=ok>Osteonecrosis</td><td align xt-marked=ok>Death of osteocytes and adipocytes and eventual bone collapse; affects hips more than knees or shoulders; risk factor is steroid use</td><td align xt-marked=ok>Pain control, injections, joint replacement</td></tr><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink xt-marked=ok>Dermatologic disorders (10–20%)</strong></td></tr><tr><td align xt-marked=ok>Erythema nodosum</td><td align><p xt-marked=ok>Hot, red, tender, nodules/extremities</p><p xt-marked=ok>Parallels bowel activity</p></td><td align xt-marked=ok>Reduce bowel inflammation</td></tr><tr><td align xt-marked=ok>Pyoderma gangrenosum</td><td align><p xt-marked=ok>Ulcerating, necrotic lesions on extremities, trunk, face, stoma</p><p xt-marked=ok>Independent of bowel activity</p></td><td align xt-marked=ok>Antibiotics, steroids, cyclosporine, infliximab, dapsone, azathioprine, intralesional steroids; not debridement or colectomy</td></tr><tr><td align xt-marked=ok>Psoriasis</td><td align xt-marked=ok>Unrelated to bowel activity</td><td align xt-marked=ok>Topical steroids, light therapy, methotrexate, infliximab, adalimumab, ustekinumab</td></tr><tr><td align xt-marked=ok>Pyoderma vegetans</td><td align><p xt-marked=ok>Intertriginous areas</p><p xt-marked=ok>Parallels bowel activity</p></td><td align xt-marked=ok>Evanescent; resolves without progression</td></tr><tr><td align xt-marked=ok>Pyostomatitis vegetans</td><td align><p xt-marked=ok>Mucous membranes</p><p xt-marked=ok>Parallels bowel activity</p></td><td align xt-marked=ok>Evanescent; resolves without progression</td></tr><tr><td align xt-marked=ok>Metastatic Crohn’s disease (CD)</td><td align><p xt-marked=ok>CD of the skin</p><p xt-marked=ok>Parallels bowel activity</p></td><td align xt-marked=ok>Reduce bowel inflammation</td></tr><tr><td align>Sweet syndrome</td><td align><p>Neutrophilic dermatosis</p><p>Parallels bowel activity</p></td><td align>Reduce bowel inflammation</td></tr><tr><td align>Aphthous stomatitis</td><td align><p>Oral ulcerations</p><p>Parallels bowel activity</p></td><td align>Reduce bowel inflammation/topical therapy</td></tr><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink>Ocular disorders (1–11%)</strong></td></tr><tr><td align>Uveitis</td><td align><p>Ocular pain, photophobia, blurred vision, headache</p><p>Independent of bowel activity</p></td><td align>Topical or systemic steroids</td></tr><tr><td align>Episcleritis</td><td align><p>Mild ocular burning</p><p>Parallels bowel activity</p></td><td align>Topical corticosteroids</td></tr><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink>Hepatobiliary disorders (10–35%)</strong></td></tr><tr><td align>Fatty liver</td><td align>Secondary to chronic illness, malnutrition, steroid therapy</td><td align>Improve nutrition, reduce steroids</td></tr><tr><td align>Cholelithiasis</td><td align><p>Patients with ileitis or ileal resection</p><p>Malabsorption of bile acids, depletion of bile salt pool, secretion of lithogenic bile</p></td><td align>Reduce bowel inflammation; cholecystectomy in symptomatic patients</td></tr><tr><td align>Primary sclerosing cholangitis (PSC)</td><td align><p>Intrahepatic and extrahepatic</p><p>Inflammation and fibrosis leading to biliary cirrhosis and hepatic failure</p><p>7–10% cholangiocarcinoma</p><p>Small-duct PSC involves small-caliber bile ducts and has a better prognosis</p></td><td align>ERCP/high-dose ursodiol lowers risk of colonic neoplasia; cholecystectomy in patients with gallbladder polyps due to the high incidence of malignancy</td></tr><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink>Urologic</strong></td></tr><tr><td align>Nephrolithiasis (10–20%)</td><td align>CD patients following small-bowel resection; calcium oxalate stones most common</td><td align>Low-oxalate diet; control of bowel inflammation; surgical intervention</td></tr><tr><td colspan=3 align><strong xmlns:xlink=http://www.w3.org/1999/xlink>Less common extraintestinal manifestations</strong></td></tr><tr><td align>Thromboembolic disorders</td><td align>Increased risk of venous and arterial thrombosis; factors responsible include abnormalities of the platelet-endothelial interaction, hyperhomocysteinemia, alterations in the coagulation cascade, impaired fibrinolysis, involvement of tissue factor–bearing microvesicles, disruption of the normal coagulation system by autoantibodies, and a genetic predisposition</td><td align>Anticoagulation; control of inflammation</td></tr><tr><td align>Cardiopulmonary</td><td align>Endocarditis, myocarditis, pleuropericarditis, interstitial lung disease</td><td align>Treatment is varied; stop 5-ASA agents as they can rarely cause interstitial lung disease</td></tr><tr><td align>Systemic amyloidosis</td><td align>Secondary (reactive) in long-standing IBD, especially CD</td><td align>Colchicine</td></tr><tr><td align>Pancreatitis</td><td align>Duodenal fistulas, ampullary CD, gallstones, PSC, drugs (MP, azathioprine, 5-ASAs), autoimmune, primary CD of the pancreas</td><td align>Treatment is varied; stop offending medication; diagnose and treat with ERCP and/or cholecystectomy</td></tr></tbody></table></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>↩️ 反向連結</h3><ul class=backlinks><li><a href=/inflammatory-bowel-disease/ data-ctx="extraintestinal manifestations of inflammatory bowel disease" data-src=/inflammatory-bowel-disease class=internal-link>inflammatory bowel disease</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>🤯互動圖</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div><div id=contact_buttons><footer><p>本網站是由 Hsieh-Ting Lin 以❤️ 用 <a href=https://github.com/jackyzha0/quartz>Quartz</a>這個酷東西種出來🪴 , © 2023</p><p><a href=https://www.buymeacoffee.com/htl.lizard><img src=https://cdn.buymeacoffee.com/buttons/v2/default-yellow.png width=200></a></p><ul><li><a href=https://www.physician.tw/>🏠首頁</a></li><li><a href=https://www.facebook.com/htlin.lizard>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://htlin222.medium.com>Medium</a></li></ul></footer></div></div></body></html>